MARKET

AVNS

AVNS

Avanos Medical
NYSE

Real-time Quotes | Nasdaq Last Sale

36.06
-0.98
-2.65%
Opening 15:53 10/28 EDT
OPEN
36.29
PREV CLOSE
37.04
HIGH
36.43
LOW
35.58
VOLUME
101.63K
TURNOVER
--
52 WEEK HIGH
48.07
52 WEEK LOW
19.46
MARKET CAP
1.72B
P/E (TTM)
-101.6061
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile
Here's Why You Should Retain Avanos Medical Stock for Now
Zacks · 09/18 13:56
Avanos Medical, Inc. Appoints Michelle Scharfenberg as Senior Vice President & Chief Ethics and Compliance Officer
Avanos Medical, Inc. (NYSE: AVNS) today announced that Michelle Scharfenberg has been named as the company's senior vice president & chief ethics and compliance officer.
PR Newswire · 09/15 12:00
Avanos Medical, Inc. to Present at Two Virtual Investor Conferences in September
Avanos Medical, Inc. (NYSE: AVNS) today announced that it would present at the following two virtual investor conferences in September:
PR Newswire · 09/04 11:00
Why Is Avanos Medical (AVNS) Up 5.7% Since Last Earnings Report?
Avanos Medical (AVNS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Zacks · 09/03 15:31
Avanos Medical, Inc. Announces Publication of Clinical Trial Demonstrating Superiority of COOLIEF* over Hyaluronic Acid Injections for the Management of Chronic Knee Pain
Avanos Medical, Inc. (NYSE: AVNS) today announced the publication of a large, randomized, multicentered clinical trial comparing the safety and efficacy of COOLIEF* Cooled Radiofrequency ablation to hyaluronic acid (HA) injection for the management of chronic knee pain caused by osteoarthritis. The results
PR Newswire · 09/03 11:00
Avanos Medical, Inc. Appoints Bill Haydon as Senior Vice President & General Manager, Pain Franchise
Avanos Medical, Inc. (NYSE: AVNS) today announced that Bill Haydon has been appointed senior vice president & general manager for the company's newly combined pain franchise. In this role, Haydon will spearhead a global strategy to support transformation and growth in this business. Previously, Haydon
PR Newswire · 08/31 21:01
Avanos Medical (AVNS) Q2 Earnings and Revenues Top Estimates
Avanos Medical's (AVNS) second-quarter results benefit from contribution from Chronic Care segment.
Zacks · 08/10 09:43
Avanos Medical (AVNS) Q2 Earnings and Revenues Surpass Estimates
Avanos Medical (AVNS) delivered earnings and revenue surprises of 262.50% and 10.19%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
Zacks · 08/04 12:55
More
Forecast
EPSBVPSCFPS
Actual (USD)
Estimate (USD)
Income StatementMore
Net IncomeTotal RevenueOperating Income
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
OperatingInvestingFinancing
Operating (USD)
YoY (%)
Learn about the latest financial forecast of AVNS. Analyze the recent business situations of Avanos Medical through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 7 analysts

Hold

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average AVNS stock price target is 36.60 with a high estimate of 43.00 and a low estimate of 31.00.
EPS
Institutional Holdings
Institutions: 415
Institutional Holdings: 50.13M
% Owned: 104.81%
Shares Outstanding: 47.83M
TypeInstitutionsShares
Increased
58
2.99M
New
45
-108.30K
Decreased
71
2.06M
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Medical Equipment, Supplies & Distribution
-2.94%
Healthcare Equipment & Supplies
-3.04%
Key Executives
Chairman/Director
Gary Blackford
Chief Executive Officer/Director
Joseph Woody
Chief Financial Officer/Senior Vice President
Michael Greiner
Senior Vice President/Chief Compliance Officer
Michelle Scharfenberg
Senior Vice President/General Counsel
John Wesley
Senior Vice President/General Manager
Bill Haydon
Senior Vice President/General Manager
William Haydon
Senior Vice President
David Ball
Senior Vice President
Arjun Sarker
Independent Director
John Byrnes
Independent Director
William Hawkins
Independent Director
Heidi Kunz
Independent Director
Patrick O'Leary
Independent Director
Maria Sainz
Independent Director
Julie Shimer
  • Dividends
  • Splits
  • Insider Activity
No Data
Access Level 2 Advance
Nasdaq TotalView
for Free
Get Now
About AVNS
Avanos Medical, Inc., formerly Halyard Health, Inc., is a medical technology company. The Company provides a portfolio of product offerings focused on surgical and interventional pain management, respiratory and digestive health. Its products include post-operative pain management solutions, minimally invasive interventional or chronic pain therapies, closed airway suction systems and enteral feeding tubes. The company’s products are sold under the ON-Q, COOLIEF, MICROCUFF, MIC-KEY, QUIKBLOC, HOMEPUMP, CORTRAK and other brand names.
More
Hot Stocks
Symbol
Price
%Change

Webull offers kinds of Avanos Medical Inc stock information, including NYSE:AVNS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AVNS stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading AVNS stock methods without spending real money on the virtual paper trading platform.